Simplex Trading’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
Other funds holding OTLK
PA
HF
GWM
Simplex Trading's OTLK Position: Q2 2026 in Review
Simplex Trading increased its Outlook Therapeutics (OTLK) stake by 55% in Q2 2026, buying an estimated $44.9K and bringing the position to 205,013 shares worth $326K. The position accounts for ﹤0.01% of the portfolio, ranked #4128.
Simplex Trading first reported a position in OTLK in Q2 2024 and has held it in 5 quarters since. 69 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.
- Simplex Trading held 205,013 shares of Outlook Therapeutics worth $326K as of Q2 2026.
- Simplex Trading bought 72,347 Outlook Therapeutics shares in Q2 2026, an estimated $44.9K.
- Outlook Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4128 holding.
- Simplex Trading first reported a position in Outlook Therapeutics in Q2 2024 and has held it in 5 quarters since.
- 69 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.